Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01721542
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
3XH | 3-Hydroxyhippuric acid | A | 3E9K | 0.73 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A | 3HF0 | 0.73 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A | 2OXK | 0.73 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A,B,C | 2OXJ | 0.73 | |
1BA | 4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE | A | 2GPP | 0.7 | |
TTS | 3-((3E)-4-HYDROXY-3-{[2-(4-HYDROXYPHENYL)ETHYL]IMINO}- 6-OXOCYCLOHEXA-1,4-DIEN-1-YL)ALANINE | A,B | 2D1W | 0.7 | |
DTY | D-TYROSINE | A | 1C4B | 0.71 | |
DTY | D-TYROSINE | A,L | 1ZEA | 0.71 | |
DTY | D-TYROSINE | A,B,C,D,E,F, G,H | 1OF6 | 0.71 | |
DTY | D-TYROSINE | A,B | 1UNO | 0.71 | |
DTY | D-TYROSINE | A | 2IGZ | 0.71 | |
DTY | D-TYROSINE | A,B,C,H,K,L | 2R5D | 0.71 | |
DTY | D-TYROSINE | A,B | 2Q33 | 0.71 | |
DTY | D-TYROSINE | H,S | 2H9E | 0.71 | |
DTY | D-TYROSINE | A,B,C,H,K,L | 2R5B | 0.71 | |
DTY | D-TYROSINE | A | 2IH0 | 0.71 | |
DTY | D-TYROSINE | A | 1D7T | 0.71 | |
DTY | D-TYROSINE | A,B | 1XA0 | 0.71 | |
RHP | (3R)-3-(PROP-2-YNYLAMINO)INDAN- 5-OL | A,B | 1S3E | 0.72 | |
ZYA | BENZOYL-TYROSINE-ALANINE-METHYL KETONE | A | 1AIM | 0.72 | |
TYB | TYROSINAL | A,B | 1KDZ | 0.71 | |
TYB | TYROSINAL | A | 1Q11 | 0.71 | |
TYB | TYROSINAL | A,B | 2J5B | 0.71 | |
TYB | TYROSINAL | A,I | 1GA4 | 0.71 | |
TYB | TYROSINAL | A,B,C | 1NLU | 0.71 | |
TYB | TYROSINAL | A,B | 1KE1 | 0.71 | |
TYB | TYROSINAL | A,B | 1H3F | 0.71 | |
TYB | TYROSINAL | A,B | 1H3E | 0.71 | |
TYP | CYCLO-(L-TYROSINE-L-PROLINE) INHIBITOR | A,B | 1W1Y | 0.72 | |
AEH | 4-(2-aminoethyl)-2-ethylphenol | A | 3BUG | 0.73 | |
OBE | 3-(3-HYDROXY-BENZOYLOXY)-8-METHYL- 8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID | H | 1RIV | 0.71 | |
MN7 | 1-CARBOXY-4-ISOBUTYLAMINOMETHYLBENZENE | N | 1NLO | 0.72 | |
LDP | L-DOPAMINE | A,B | 2A3R | 0.73 | |
LDP | L-DOPAMINE | A | 5PAH | 0.73 | |
LDP | L-DOPAMINE | A,B | 2QMZ | 0.73 | |
LDP | L-DOPAMINE | A,B | 2VQ5 | 0.73 | |
Y13 | (2E)-3-(3,4-DIHYDROXYPHENYL)-N- [2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE | A | 2EW6 | 0.84 | |
BJH | 1(R)-1-ACETAMIDO-2-(3-CARBOXY-2- HYDROXYPHENYL)ETHYL BORONIC ACID | A | 1ERQ | 0.7 | |
MTY | META-TYROSINE | A | 2TOH | 0.72 | |
MTY | META-TYROSINE | A,B | 1BIQ | 0.72 | |
MTY | META-TYROSINE | A | 1Q7O | 0.72 | |
TYC | L-TYROSINAMIDE | A | 2BF9 | 0.71 | |
TYC | L-TYROSINAMIDE | A | 2OCI | 0.71 | |
YTT | (3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine- 2,5-dione | A | 3G5H | 0.78 | |
NLT | N-DODECANOYL-L-TYROSINE | A,B,C,D,E,F, G,H | 2G0B | 0.72 | |
HXS | 4-[(1R,2S)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol | A,B | 3CV6 | 0.7 | |
DES | DIETHYLSTILBESTROL | A,B,C,D | 1S9P | 0.71 | |
DES | DIETHYLSTILBESTROL | A,B | 3ERD | 0.71 | |
DES | DIETHYLSTILBESTROL | A,B | 1TT6 | 0.71 | |
DES | DIETHYLSTILBESTROL | A,B,C,D | 1TZ8 | 0.71 | |
Y12 | 4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP- 1-EN-1-YL}-1,2-PHENYLENE DIACETATE | A | 2EW5 | 0.72 | |
SAF | 3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL | A | 1GQR | 0.74 | |
SAF | 3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL | A | 1GQS | 0.74 | |
AHT | 4-(2,5-DIAMINO-5-HYDROXY-PENTYL)- PHENOL | I,T | 1TMB | 0.7 | |
AEF | 4-(2-aminoethyl)phenol | A | 3BRA | 0.75 | |
CTA | CYCLOTHEONAMIDE A | A | 1TYN | 0.7 | |
LOB | LOBELINE | A,B,C,D,E,F, G,H,I,J | 2BYS | 0.75 | |
AEG | 4-[(2R)-2-aminopropyl]phenol | A | 3BUF | 0.74 | |
BM4 | 3-[(3R)-3-ethyl-1-{9-[(3S)-3-ethyl- 3-(3-hydroxyphenyl)azepan-1-yl]nonyl}azepan- 3-yl]phenol | X | 2W6C | 0.74 | |
OTS | 4-(2S-AMINO-1-HYDROXYETHYL)PHENOL | A,B | 1RG2 | 0.71 | |
OTS | 4-(2S-AMINO-1-HYDROXYETHYL)PHENOL | A,B | 1RG1 | 0.71 | |
OTS | 4-(2S-AMINO-1-HYDROXYETHYL)PHENOL | A,B | 1RH0 | 0.71 | |
OTS | 4-(2S-AMINO-1-HYDROXYETHYL)PHENOL | A,B | 1RGU | 0.71 | |
OTS | 4-(2S-AMINO-1-HYDROXYETHYL)PHENOL | A,B | 1RGT | 0.71 | |
109 | 2-(4-CARBAMIMIDOYL-2-HYDROXY-BENZYLAMINO)- PROPIONIC ACID | A | 1G3C | 0.71 | |
109 | 2-(4-CARBAMIMIDOYL-2-HYDROXY-BENZYLAMINO)- PROPIONIC ACID | A | 1G3E | 0.71 | |
SGI | 3-(4-hydroxyphenyl)propanamide | A,B | 2R9K | 0.72 | |
TNC | 4-DIMETHYLAMINO-1,10,11,12-TETRAHYDROXY- 3-OXO-3,4,4A,5-TETRAHYDRO-NAPHTHACENE- 2-CARBOXYLIC ACID AMIDE | A,B | 1N5Q | 0.71 | |
3QC | (4R)-4-(3-HYDROXYPHENYL)-N,N,7,8- TETRAMETHYL-3,4-DIHYDROISOQUINOLINE- 2(1H)-CARBOXAMIDE | A,B | 2FME | 0.74 | |
MOY | [(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL- 2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN- 5-YL](PHENYL)METHANONE | A,B | 2IEH | 0.76 | |
OTR | 4-(2R-AMINO-1-HYDROXYETHYL)PHENOL | A,B | 1RGT | 0.71 | |
OTR | 4-(2R-AMINO-1-HYDROXYETHYL)PHENOL | A,B | 1RG2 | 0.71 | |
OTR | 4-(2R-AMINO-1-HYDROXYETHYL)PHENOL | A,B | 2AN4 | 0.71 | |
ALE | L-EPINEPHRINE | A | 3PAH | 0.71 | |
ALE | L-EPINEPHRINE | A | 2HKK | 0.71 | |
4BA | 4-[(2-CARBOXY-ETHYLAMINO)-METHYL]- BENZOIC ACID | C | 1FAV | 0.71 | |
AED | 4-(2-aminoethyl)-2-cyclohexylphenol | A | 3BUH | 0.73 | |
BJP | (1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID | A | 1ERO | 0.71 | |
ECA | N,N',N''-[BENZENE-1,3,5-TRIYLTRIS(METHYLENE)]TRIS(2,3- DIHYDROXYBENZAMIDE) | A,B | 2CHU | 0.71 |